glp-1 supply chain news Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 The GLP-1 Inflection: Why March
Description
The number of subscribers using personalized solutions grew 50% year over year in the third quarter of 2025, according to the company.
But eating less is not the goal
[DOI] [PubMed] [Google Scholar] 55.Kawatani M, et al
Research fuels more research
Human GLP-1 based GLP-1RA includes liraglutide, albiglutide, dulaglutide, efpeglenatide, and semaglutide
